Pharmaceutical Drug Targets and Diseases: Difference between revisions

Jump to navigation Jump to search
← Older editNewer edit →
David Canner (talk | contribs)
7,699 edits
No edit summary
David Canner (talk | contribs)
7,699 edits
No edit summary
Line 24: Line 24:


**Bacterial Infections
**Bacterial Infections
***[[Chloramphenicol Acetyltransferase Type III]]
*** See: [[Bacterial Infections]]
***[[Gyrase]] - Target of the Quinolones
***[[User:Wayne Decatur/Interactions between Antibiotics and the Ribosome|Interactions between Antibiotics & the Ribosome]]
***[[Large Ribosomal Subunit of Haloarcula|Large Ribosomal Subunit]]
***[[User:Wayne Decatur/Haloarcula Large Ribosomal Subunit With Azithromycin|Large Ribosomal Subunit with Azithromycin]]
***[[Molecular_Playground/PcrA_Helicase|PcrA Helicase]]


**Blood Clots, Haemophilia, & Thrombic Events
**Blood Clots, Haemophilia, & Thrombic Events
***[[P2Y12]]
***[[P2Y12]]
***Haemophilia
***Haemophilia
**** See: [[Hemophelia]]
**** See: [[Hemophilia]]


**Cancer
**Cancer

Proteopedia Page Contributors and Editors (what is this?)Proteopedia Page Contributors and Editors (what is this?)

David Canner, Thomas J. Stout, Eran Hodis, Wayne Decatur, Alexander Berchansky
Retrieved from "https://proteopedia.openfox.io/w/Pharmaceutical_Drug_Targets_and_Diseases"